Envision Healthcare (EVHC) Reports In-Line Q3 EPS
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Envision Healthcare (NYSE: EVHC) reported Q3 EPS of $0.36, in-line with the analyst estimate of $0.36. Revenue for the quarter came in at $1.64 billion versus the consensus estimate of $1.67 billion.
Envision Healthcare sees FY2016 EPS of $1.39-$1.42, versus the consensus of $1.43.
- now expects to generate Adjusted EBITDA of $705 million to $715 million
For earnings history and earnings-related data on Envision Healthcare (EVHC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs (GS) Tops Q4 EPS by 26c
- PrivateBancorp (PVTB) Tops Q4 EPS by 7c; Continues to Work Toward CIBC Merger
- Target (TGT) November/December Comps Fell 1.3%; Lowers Guidance
Create E-mail Alert Related CategoriesEarnings, Guidance
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!